Canada markets closed

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.8022+0.1122 (+6.64%)
At close: 04:00PM EDT
1.8400 +0.04 (+2.10%)
After hours: 07:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 17.06M
Enterprise Value 80.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.06
Price/Book (mrq)5.11
Enterprise Value/Revenue 1.42
Enterprise Value/EBITDA -3.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-66.06%
S&P500 52-Week Change 322.38%
52 Week High 35.5000
52 Week Low 31.6600
50-Day Moving Average 32.0328
200-Day Moving Average 32.7345

Share Statistics

Avg Vol (3 month) 317.81k
Avg Vol (10 day) 310.17k
Shares Outstanding 59.47M
Implied Shares Outstanding 67.64M
Float 885.64M
% Held by Insiders 123.67%
% Held by Institutions 131.57%
Shares Short (Apr 15, 2024) 41.86k
Short Ratio (Apr 15, 2024) 40.1
Short % of Float (Apr 15, 2024) 40.04%
Short % of Shares Outstanding (Apr 15, 2024) 40.02%
Shares Short (prior month Mar 15, 2024) 44.3k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.19
Payout Ratio 40.00%
Dividend Date 3Jul 01, 2015
Ex-Dividend Date 4Jun 05, 2015
Last Split Factor 21:5
Last Split Date 3Feb 23, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -42.26%
Operating Margin (ttm)-25.98%

Management Effectiveness

Return on Assets (ttm)-13.26%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)56.83M
Revenue Per Share (ttm)7.42
Quarterly Revenue Growth (yoy)-25.60%
Gross Profit (ttm)N/A
EBITDA -14.3M
Net Income Avi to Common (ttm)-36.87M
Diluted EPS (ttm)-4.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.69M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)67.43M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.60
Book Value Per Share (mrq)-3.12

Cash Flow Statement

Operating Cash Flow (ttm)-11.56M
Levered Free Cash Flow (ttm)-12.83M